Addex Therapeutics Ltd (ADXN) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.14x

Addex Therapeutics Ltd (ADXN) has a Cash Flow Reinvestment Rate of 0.14x as of December 2020, reinvesting $96.17K (capex $48.09K plus investments $-48.09K) from operating cash flow of $704.85K. Explore Addex Therapeutics Ltd (ADXN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.14x

(Capex + Investments) / Operating CF

Total Reinvested

$96.17K

Capex + Investments

Operating Cash Flow

$704.85K

USD

Capital Expenditures

$48.09K

USD

Addex Therapeutics Ltd Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Addex Therapeutics Ltd across 1 annual periods. Also explore ADXN asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Addex Therapeutics Ltd (2018–2018)

Year-by-year capital reinvestment analysis for Addex Therapeutics Ltd. For live market cap and broader valuation context, see Addex Therapeutics Ltd (ADXN) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2018	0.03x	$56.37K	$1.75 Million	$9.05K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow